Drug Monitoring, Eszopiclone, Quantitative, Urine
Test Summary
N/A
Aliases
- Lunesta®
- Pain Management
- Prescription Drug Monitoring
Specimen Collection
Special Instructions
N/A
Preferred Specimen
3 mL unpreserved urine
Minimum Volume
2 mL
Instructions
N/A
Patient Preparation
N/A
Storage
Frozen
Transport Temperature
Frozen
Specimen Stability
Room temperature: unacceptable
Refrigerated: unacceptable
Frozen: 30 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
Preserved urine
Order Code
ESZOP
EPIC (Premier) Code
LAB6942
Includes
Eszopiclone and Eszopiclone Metabolite
CPT Code
83068
Billing Code
671358
CPT Statement
Methodology
Chromatography/Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Physician Attestation of Informed Consent
N/A
Testing Laboratory
33608 Ortega Highway
San Juan Capistrano CA, 92675
Department
Reference Range
Eszopiclone <5 ng/mL
Eszopiclone Metabolite <5 ng/mL
Setup Schedule / Expected Turnaround Time
Tuesday - Saturday; Report available: 2 - 4 days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
3 mL unpreserved urine
Minimum Volume
2 mL
Instructions
N/A
Patient Preparation
N/A
Storage
Frozen
Transport Temperature
Frozen
Specimen Stability
Room temperature: unacceptable
Refrigerated: unacceptable
Frozen: 30 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
Preserved urine
Result Information
Methodology
Chromatography/Mass Spectrometry
Testing Laboratory
Reference Range
Eszopiclone <5 ng/mL
Eszopiclone Metabolite <5 ng/mL
Setup Schedule / Expected Turnaround Time
Tuesday - Saturday; Report available: 2 - 4 days